|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Ulitsky I and Bartel DP: lincRNAs:
genomics, evolution, and mechanism. Cell. 154:26–46.
2013.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Chen LL: Linking long noncoding RNA
localization and function. Trends Biochem Sci. 41:761–772.
2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Hung T and Chang HY: Long noncoding RNA in
genome regulation: Prospects and mechanisms. RNA Biol. 7:582–585.
2010.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Yamashita A, Shichino Y and Yamamoto M:
The long non-coding RNA world in yeasts. Biochim Biophys Acta.
1859:147–154. 2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Loewen G, Jayawickramarajah J, Zhuo Y and
Shan B: Functions of lncRNA HOTAIR in lung cancer. J Hematol Oncol.
7(90)2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Iguchi T, Uchi R, Nambara S, Saito T,
Komatsu H, Hirata H, Ueda M, Sakimura S, Takano Y, Kurashige J, et
al: A long noncoding RNA, lncRNA-ATB, is involved in the
progression and prognosis of colorectal cancer. Anticancer Res.
35:1385–1388. 2015.PubMed/NCBI
|
|
8
|
Flicek P, Ahmed I, Amode MR, Barrell D,
Beal K, Brent S, Carvalho-Silva D, Clapham P, Coates G, Fairley S,
et al: Ensembl 2013. Nucleic Acids Res. 41 (D1):D48–D55.
2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Klingenberg M, Groß M, Goyal A,
Polycarpou-Schwarz M, Miersch T, Ernst AS, Leupold J, Patil N,
Warnken U, Allgayer H, et al: The long noncoding RNA cancer
susceptibility 9 and RNA binding protein heterogeneous nuclear
ribonucleoprotein L form a complex and coregulate genes linked to
AKT signaling. Hepatology. 68:1817–1832. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Cao W, Wu W, Shi F, Chen X, Wu L, Yang K,
Tian F, Zhu M, Chen G, Wang W, et al: Integrated analysis of long
noncoding RNA and coding RNA expression in esophageal squamous cell
carcinoma. Int J Genomics. 2013:480534–480543. 2013.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Su X, Li G and Liu W: The long noncoding
RNA cancer susceptibility candidate 9 promotes nasopharyngeal
carcinogenesis via stabilizing HIF1a. DNA Cell Biol. 36:394–400.
2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Yang Y, Chen D, Liu H and Yang K:
Increased expression of lncRNA CASC9 promotes tumor progression by
suppressing autophagy-mediated cell apoptosis via the AKT/mTOR
pathway in oral squamous cell carcinoma. Cell Death Dis. 10:41–56.
2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Gao L, Guo YN, Zeng JH, Ma FC, Luo J, Zhu
HW, Xia S, Wei KL and Chen G: The expression, significance and
function of cancer susceptibility candidate 9 in lung squamous cell
carcinoma: A bioinformatics and in vitro investigation. Int J
Oncol. 54:1651–1664. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Shao G, Wang M, Fan X, Zhong L, Wang Z,
Zhang P and Ji S: lncRNA CASC9 positively regulates CHK1 to promote
breast cancer cell proliferation and survival through sponging the
miR 195/497 cluster. Int J Oncol. 54:1665–1675. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Fang J, Chen W and Meng XL: lncRNA CASC9
Suppressed the Apoptosis of gastric cancer cells through regulating
BMI1. Pathol Oncol Res. 10:22–29. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Yu X, Lin Y, Sui W, Zou Y and Lv Z:
Analysis of distinct long noncoding RNA transcriptional
fingerprints in pancreatic ductal adenocarcinoma. Cancer Med.
6:673–680. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Luo K, Geng J, Zhang Q, Xu Y, Zhou X,
Huang Z, Shi KQ, Pan C and Wu J: lncRNA CASC9 interacts with CPSF3
to regulate TGF-β signaling in colorectal cancer. J Exp Clin Cancer
Res. 38:249–264. 2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Hu X, Li Y, Kong D, Hu L, Liu D and Wu J:
Long noncoding RNA CASC9 promotes LIN7A expression via miR-758-3p
to facilitate the malignancy of ovarian cancer. J Cell Physiol.
234:10800–10808. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zhang J, Wang Q and Quan Z: Long
non-coding RNA CASC9 enhances breast cancer progression by
promoting metastasis through the meditation of miR-215/TWIST2
signaling associated with TGF-β expression. Biochem Biophys Res
Commun. 515:644–650. 2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Pan Z, Mao W, Bao Y, Zhang M, Su X and Xu
X: The long noncoding RNA CASC9 regulates migration and invasion in
esophageal cancer. Cancer Med. 5:2442–2447. 2016.PubMed/NCBI View
Article : Google Scholar
|
|
21
|
Wu Y, Hu L, Liang Y, Li J, Wang K, Chen X,
Meng H, Guan X, Yang K and Bai Y: Up-regulation of lncRNA CASC9
promotes esophageal squamous cell carcinoma growth by negatively
regulating PDCD4 expression through EZH2. Mol Cancer. 16:150–163.
2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Liang Y, Chen X, Wu Y, Li J, Zhang S, Wang
K, Guan X, Yang K and Bai Y: lncRNA CASC9 promotes esophageal
squamous cell carcinoma metastasis through upregulating LAMC2
expression by interacting with the CREB-binding protein. Cell Death
Differ. 25:1980–1995. 2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Gao GD, Liu XY, Lin Y, Liu HF and Zhang
GJ: lncRNA CASC9 promotes tumorigenesis by affecting EMT and
predicts poor prognosis in esophageal squamous cell cancer. Eur Rev
Med Pharmacol Sci. 22:422–429. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Moher D, Liberati A, Tetzlaff J, Altman DG
and Group P: PRISMA Group. Preferred reporting items for systematic
reviews and meta-analyses: The PRISMA statement. PLoS Med.
6(e1000097)2009.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Tierney JF, Stewart LA, Ghersi D, Burdett
S and Sydes MR: Practical methods for incorporating summary
time-to-event data into meta-analysis. Trials. 8(16)2007.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Stang A: Critical evaluation of the
Newcastle-Ottawa scale for the assessment of the quality of
nonrandomized studies in meta-analyses. Eur J Epidemiol.
25:603–605. 2010.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wong WC, Cheung CS and Hart GJ:
Development of a quality assessment tool for systematic reviews of
observational studies (QATSO) of HIV prevalence in men having sex
with men and associated risk behaviours. Emerg Themes Epidemiol.
5:23–26. 2008.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Begg CB and Mazumdar M: Operating
characteristics of a rank correlation test for publication bias.
Biometrics. 50:1088–1101. 1994.PubMed/NCBI
|
|
29
|
Duval S and Tweedie R: Trim and fill: A
simple funnel-plot-based method of testing and adjusting for
publication bias in meta-analysis. Biometrics. 56:455–463.
2000.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Mathieu EL, Belhocine M, Dao LT, Puthier D
and Spicuglia S: Functions of lncRNA in development and diseases.
Med Sci (Paris). 30:790–796. 2014.PubMed/NCBI View Article : Google Scholar : (In French).
|
|
31
|
Peng WX, Koirala P and Mo YY:
lncRNA-mediated regulation of cell signaling in cancer. Oncogene.
36:5661–5667. 2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Gao P and Wei GH: Genomic insight into the
role of lncRNA in cancer susceptibility. Int J Mol Sci.
18:1239–1249. 2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Yarmishyn AA and Kurochkin IV: Long
noncoding RNAs: A potential novel class of cancer biomarkers. Front
Genet. 6:145–154. 2015.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Evans JR, Feng FY and Chinnaiyan AM: The
bright side of dark matter: lncRNAs in cancer. J Clin Invest.
126:2775–2782. 2016.PubMed/NCBI View
Article : Google Scholar
|
|
35
|
Zhao QS, Li L, Zhang L, Meng XW, Li LL, Ge
XF and Li ZP: Over-expression of lncRNA SBF2-AS1 is associated with
advanced tumor progression and poor prognosis in patients with
non-small cell lung cancer. Eur Rev Med Pharmacol Sci.
20:3031–3034. 2016.PubMed/NCBI
|
|
36
|
Qi P and Du X: The long non-coding RNAs, a
new cancer diagnostic and therapeutic gold mine. Mod Pathol.
26:155–165. 2013.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Wang JJ, Huang YQ, Song W, Li YF, Wang H,
Wang WJ and Huang M: Comprehensive analysis of the lncRNA
associated competing endogenous RNA network in breast cancer. Oncol
Rep. 42:2572–2582. 2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Wang X, Zhou X, Liu J, Liu Z, Zhang L,
Gong Y, Huang J, Yu L, Wang Q, Yang C, et al: Genome wide
investigation of the clinical implications and molecular mechanism
of long noncoding RNA LINC00668 and protein coding genes in
hepatocellular carcinoma. Int J Oncol. 55:860–878. 2019.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Jiang B, Li Y, Qu X, Zhu H, Tan Y, Fan Q,
Jiang Y, Liao M and Wu X: Long noncoding RNA cancer susceptibility
candidate 9 promotes doxorubicin resistant breast cancer by binding
to enhancer of zeste homolog 2. Int J Mol Med. 42:2801–2810.
2018.PubMed/NCBI View Article : Google Scholar
|
